A detailed history of Merit Financial Group, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Merit Financial Group, LLC holds 2,536 shares of UTHR stock, worth $979,580. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,536
Previous 1,846 37.38%
Holding current value
$979,580
Previous $588,000 54.42%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$311.04 - $363.55 $214,617 - $250,849
690 Added 37.38%
2,536 $908,000
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $421,367 - $588,947
1,846 New
1,846 $588,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.